Identification of Differentially Expressed Genes and Fusion Genes Associated with Malignant Progression of Spinal Cord Gliomas by Transcriptome Analysis

Overview

Journal Sci Rep

Specialty Science

Date 2019 Sep 21

PMID 31537867

Citations 4

Authors

Dong-Kang Liu

Jin Wang

Yi Guo

Zhen-Xing Sun

Gui-Huai Wang

Affiliations

Soon will be listed here.

Abstract

Glioma, the most common histological subtype of primary spinal cord tumors, is considered as a rare central nervous system neoplasm. In this study, 9 glioma samples (4 of grade II and 5 of grade IV with H3K27M positive) were analyzed to examine the molecular mechanisms underlying the malignant progression of gliomas, transcriptome sequencing. Differentially expressed genes (DEGs) in grade IV vs. grade II were analyzed by using the Limma package in R. Enrichment analysis was performed for the individual DEGs through VennPlex software and the Database for Annotation. Gene mutations and fusions were analyzed using the Genome Analysis Toolkit and STAR-Fusion. A total of 416 DEGs were identified in grade IV vs. grade II. Functional analysis of the DEGs showed that GALR1 and GRM5 of neuroactive ligand-receptor interactions signaling pathways may be relaed to malignant progression of gliomas. Further systematic transcriptional profiling identified 11 in-frame/frameshift gene fusions in the tumors. Notably, one novel gene fusions, GATSL2-GTF2I was detected in all of the grade II samples. In summary, the molecular alterations observed in glioma progression may improve the characterization of different human spinal cord glioma grades. The transcriptome analysis of intramedullary spinal cord glioma will provide a new candidate gene list for further mechanism research.

Citing Articles

Retinol dehydrogenase 10 promotes epithelial-mesenchymal transition in spinal cord gliomas via PI3K/AKT pathway.

Zhao Z, Song Z, Wang Z, Zhang F, Ding Z, Zhao Z Int J Immunopathol Pharmacol. 2024; 38:3946320241276336.

PMID: 39180753 PMC: 11344904. DOI: 10.1177/03946320241276336.

Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis.

Li X, Jiang P, Li R, Wu B, Zhao K, Li S Front Oncol. 2022; 12:1009036.

PMID: 36408192 PMC: 9666696. DOI: 10.3389/fonc.2022.1009036.

Circ_0007534 Silencing Inhibits the Proliferation, Migration and Invasion and Induces the Apoptosis of Glioma Cells Partly Through Down-Regulating PROX1 Via Elevating miR-22-3p Level.

Zheng Y, Wang Y, Mai R, Liu L, Zhu Z, Cao Y Cell Mol Neurobiol. 2021; 42(8):2819-2832.

PMID: 34536179 PMC: 11421593. DOI: 10.1007/s10571-021-01150-y.

Association of GTF2I, NFKB1, and TYK2 Regional Polymorphisms With Systemic Sclerosis in a Chinese Han Population.

Liu C, Yan S, Chen H, Wu Z, Li L, Cheng L Front Immunol. 2021; 12:640083.

PMID: 34248934 PMC: 8261294. DOI: 10.3389/fimmu.2021.640083.

References

Cabili M, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A . Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011; 25(18):1915-27. PMC: 3185964. DOI: 10.1101/gad.17446611. View

McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A . The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-303. PMC: 2928508. DOI: 10.1101/gr.107524.110. View

Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View

Mannaioni G, Marino M, Valenti O, Traynelis S, Conn P . Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function. J Neurosci. 2001; 21(16):5925-34. PMC: 6763150. View

Wei B, Wang L, Du C, Hu G, Wang L, Jin Y . Identification of differentially expressed genes regulated by transcription factors in glioblastomas by bioinformatics analysis. Mol Med Rep. 2014; 11(4):2548-54. PMC: 4337481. DOI: 10.3892/mmr.2014.3094. View

Jiang T, Mao Y, Ma W, Mao Q, You Y, Yang X . CGCG clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett. 2016; 375(2):263-273. DOI: 10.1016/j.canlet.2016.01.024. View

Ozsolak F, Milos P . RNA sequencing: advances, challenges and opportunities. Nat Rev Genet. 2010; 12(2):87-98. PMC: 3031867. DOI: 10.1038/nrg2934. View

Seki T, Hida K, Yano S, Aoyama T, Koyanagi I, Houkin K . Surgical Outcomes of High-Grade Spinal Cord Gliomas. Asian Spine J. 2015; 9(6):935-41. PMC: 4686401. DOI: 10.4184/asj.2015.9.6.935. View

Kim D, Langmead B, Salzberg S . HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015; 12(4):357-60. PMC: 4655817. DOI: 10.1038/nmeth.3317. View

10.

Jones D, Kocialkowski S, Liu L, Pearson D, Ichimura K, Collins V . Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. Oncogene. 2009; 28(20):2119-23. PMC: 2685777. DOI: 10.1038/onc.2009.73. View

11.

Anders S, Pyl P, Huber W . HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2014; 31(2):166-9. PMC: 4287950. DOI: 10.1093/bioinformatics/btu638. View

12.

Berger A, Santic R, Almer D, Hauser-Kronberger C, Huemer M, Humpel C . Galanin and galanin receptors in human gliomas. Acta Neuropathol. 2003; 105(6):555-60. DOI: 10.1007/s00401-003-0680-7. View

13.

Kaul A, Chen Y, Emnett R, Dahiya S, Gutmann D . Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner. Genes Dev. 2012; 26(23):2561-6. PMC: 3521628. DOI: 10.1101/gad.200907.112. View

14.

Fakhreddine M, Mahajan A, Penas-Prado M, Weinberg J, McCutcheon I, Puduvalli V . Treatment, prognostic factors, and outcomes in spinal cord astrocytomas. Neuro Oncol. 2013; 15(4):406-12. PMC: 3607259. DOI: 10.1093/neuonc/nos309. View

15.

Xu Y, Wang J, Xu Y, Xiao H, Li J, Wang Z . Screening critical genes associated with malignant glioma using bioinformatics analysis. Mol Med Rep. 2017; 16(5):6580-6589. PMC: 5865802. DOI: 10.3892/mmr.2017.7471. View

16.

Hsu S, Quattrone M, Ostrom Q, Ryken T, Sloan A, Barnholtz-Sloan J . Incidence patterns for primary malignant spinal cord gliomas: a Surveillance, Epidemiology, and End Results study. J Neurosurg Spine. 2011; 14(6):742-7. PMC: 3742012. DOI: 10.3171/2011.1.SPINE10351. View

17.

Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2):97-109. PMC: 1929165. DOI: 10.1007/s00401-007-0243-4. View

18.

Li Y, Wang D, Wang L, Yu J, Du D, Chen Y . Distinct genomic aberrations between low-grade and high-grade gliomas of Chinese patients. PLoS One. 2013; 8(2):e57168. PMC: 3579804. DOI: 10.1371/journal.pone.0057168. View

19.

Bao Z, Chen H, Yang M, Zhang C, Yu K, Ye W . RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas. Genome Res. 2014; 24(11):1765-73. PMC: 4216918. DOI: 10.1101/gr.165126.113. View

20.

Lin A, Rodriguez F, Karajannis M, Williams S, Legault G, Zagzag D . BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants. J Neuropathol Exp Neurol. 2011; 71(1):66-72. PMC: 4629834. DOI: 10.1097/NEN.0b013e31823f2cb0. View